Sandbox:Preeti: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Undo revision 1510704 by Preeti Singh (talk)
Tag: Undo
No edit summary
Line 4: Line 4:


{| class="wikitable"
{| class="wikitable"
! colspan="3" |
! colspan="3" rowspan="2" |
!Differentiating Symptoms
! rowspan="2" |Pathophysiology
!Differentiating physical exam findings
! rowspan="2" |Symptoms
!Differentiating Labs
! rowspan="2" |History
! rowspan="2" |Physical  Examination
! colspan="3" |Laboratory Findings
|-
!Immunochemistry
!Blood work
!Biospy
|-
|-
| rowspan="10" |'''Infections'''  
| rowspan="10" |'''Infections'''  
| rowspan="4" |'''Bacterial'''  
| rowspan="4" |'''Bacterial'''  
| rowspan="2" |Syphilis
| rowspan="2" |Syphilis
|
|
|
|
|
|
|
|
|
|
|-
|-
|
|
|
|
|
|
|
|
Line 21: Line 35:
|-
|-
| rowspan="2" |Brucellosis
| rowspan="2" |Brucellosis
|
|
|
|
|
|
|
|
|
|
|-
|-
|
|
|
|
|
|
|
|
Line 31: Line 53:
| rowspan="4" |'''Viral'''  
| rowspan="4" |'''Viral'''  
|infectious mononucleosis
|infectious mononucleosis
|
|
|
|
|
|
|
|
Line 36: Line 62:
|-
|-
|cytomegalovirus
|cytomegalovirus
|
|
|
|
|
|
|
|
Line 41: Line 71:
|-
|-
|human immunodeficiency virus
|human immunodeficiency virus
|
|
|
|
|
|
|
|
Line 46: Line 80:
|-
|-
|cat scratch fever
|cat scratch fever
|
|
|
|
|
|
|
|
Line 52: Line 90:
|'''Mycobacterial'''
|'''Mycobacterial'''
|tuberculosis
|tuberculosis
|
|
|
|
|
|
|
|
Line 58: Line 100:
|'''Parasitic'''  
|'''Parasitic'''  
|toxoplasmosis
|toxoplasmosis
|
|
|
|
|
|
|
|
Line 64: Line 110:
| rowspan="4" |'''Autoimmune'''
| rowspan="4" |'''Autoimmune'''
|'''Systemic lupus erythematosus'''
|'''Systemic lupus erythematosus'''
|
|
|
|
|
|
|
|
Line 70: Line 120:
|-
|-
|'''Sjögren's syndrome'''
|'''Sjögren's syndrome'''
|
|
|
|
|
|
|
|
Line 76: Line 130:
|-
|-
|'''Hydantoin derivatives'''
|'''Hydantoin derivatives'''
|
|
|
|
|
|
|
|
Line 82: Line 140:
|-
|-
|'''Sarcoidosis'''
|'''Sarcoidosis'''
|
|
|
|
|
|
|
|
Line 89: Line 151:
| rowspan="6" |'''Neoplasms'''
| rowspan="6" |'''Neoplasms'''
| colspan="1" rowspan="1" |'''Hodgkin's disease'''
| colspan="1" rowspan="1" |'''Hodgkin's disease'''
|
|
|
|
|
|
|
|
Line 95: Line 161:
|-
|-
| colspan="1" rowspan="1" |'''Chronic lymphocytic leukemia'''
| colspan="1" rowspan="1" |'''Chronic lymphocytic leukemia'''
|
|
|
|
|
|
|
|
Line 101: Line 171:
|-
|-
| colspan="1" rowspan="1" |'''Small cell carcinoma of the lung'''
| colspan="1" rowspan="1" |'''Small cell carcinoma of the lung'''
|
|
|
|
|
|
|
|
Line 107: Line 181:
|-
|-
| colspan="1" rowspan="1" |'''Malignant histiocytosis'''
| colspan="1" rowspan="1" |'''Malignant histiocytosis'''
|
|
|
|
|
|
|
|
Line 113: Line 191:
|-
|-
| colspan="1" rowspan="1" |'''Melanoma'''
| colspan="1" rowspan="1" |'''Melanoma'''
|
|
|
|
|
|
|
|
Line 119: Line 201:
|-
|-
| colspan="1" rowspan="1" |'''Germ cell neoplasms'''
| colspan="1" rowspan="1" |'''Germ cell neoplasms'''
|
|
|
|
|
|
|
|
Line 126: Line 212:
| rowspan="5" |'''Other conditions'''
| rowspan="5" |'''Other conditions'''
| colspan="1" rowspan="1" |'''Reactive lymphoid hyperplasia'''
| colspan="1" rowspan="1" |'''Reactive lymphoid hyperplasia'''
|
|
|
|
|
|
|
|
Line 133: Line 223:
| colspan="1" rowspan="1" |'''Lymphomatoid granulomatosis'''
| colspan="1" rowspan="1" |'''Lymphomatoid granulomatosis'''
|Diabetic coma
|Diabetic coma
|
|
|
|
|
|
|
|
Line 139: Line 233:
| colspan="1" rowspan="1" |'''Dermatopathic lymphadenopathy'''
| colspan="1" rowspan="1" |'''Dermatopathic lymphadenopathy'''
|Acidosis
|Acidosis
|
|
|
|
|
|
|
|
Line 145: Line 243:
| colspan="1" rowspan="1" |'''Angioimmunoblastic lymphadenopathy'''
| colspan="1" rowspan="1" |'''Angioimmunoblastic lymphadenopathy'''
|Thyroid strom
|Thyroid strom
|
|
|
|
|
|
|
|
Line 151: Line 253:
| colspan="1" rowspan="1" |'''Giant lymph node hyperplasia (Castleman disease)'''
| colspan="1" rowspan="1" |'''Giant lymph node hyperplasia (Castleman disease)'''
|Acute Gout
|Acute Gout
|
|
|
|
|
|
|
|
Line 158: Line 264:
|
|
|Seizures
|Seizures
|
|
|
|
|
|
|
|
|
|
|}
|}

Revision as of 15:31, 19 December 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]

Pathophysiology Symptoms History Physical Examination Laboratory Findings
Immunochemistry Blood work Biospy
Infections Bacterial Syphilis
Brucellosis
Viral infectious mononucleosis
cytomegalovirus
human immunodeficiency virus
cat scratch fever
Mycobacterial tuberculosis
Parasitic toxoplasmosis
Autoimmune Systemic lupus erythematosus
Sjögren's syndrome
Hydantoin derivatives
Sarcoidosis
Neoplasms Hodgkin's disease
Chronic lymphocytic leukemia
Small cell carcinoma of the lung
Malignant histiocytosis
Melanoma
Germ cell neoplasms
Other conditions Reactive lymphoid hyperplasia
Lymphomatoid granulomatosis Diabetic coma
Dermatopathic lymphadenopathy Acidosis
Angioimmunoblastic lymphadenopathy Thyroid strom
Giant lymph node hyperplasia (Castleman disease) Acute Gout
Seizures
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox:Preeti&oldid=1510711"